Who owns TransCure bioServices?

TransCure bioServices is formerly owned by Cathay Capital, through Cathay Capital Midcap II, since 2022.

When did Cathay Capital acquire TransCure bioServices?

Cathay Capital acquired TransCure bioServices in 2022 and exited after 4 years.

Yes. TransCure bioServices was exited in 2026 via Trade Sale.

Home/Companies/Healthcare/TransCure bioServices

Healthcare·

France·Exited 2026·Held 4yr

TransCure bioServices is a healthcare company, headquartered in France.

Entry

2022

Hold

4yr

Exit

2026

Est. EV

–

Investor

HQFrance

SectorHealthcare

French CRO specializing in preclinical services. Acquired by Taconic Biosciences (US) in January 2026.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Cathay Capital Midcap II

6 comparable healthcare deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

Data refreshed weekly · Sourced from public filings